KRT14

KRT14 is a type I intermediate filament keratin expressed in basal epithelial cells, where it forms obligate heterodimers with KRT5 to provide mechanical integrity and regulate cell fate decisions including differentiation, apoptosis, and progenitor cell self-renewal. Dominant-negative mutations in the KRT14 rod domain disrupt filament polymerization and cause epidermolysis bullosa simplex (EBS), with helix boundary motif mutations producing the most severe Dowling-Meara phenotype, while haploinsufficient mutations in the N-terminal head domain cause distinct ectodermal dysplasias (NFJS/DPR) through increased susceptibility to TNF-α-induced apoptosis (PMID:21375516, PMID:16960809, PMID:18049449). Beyond structural roles, KRT14 directly binds stratifin to regulate airway basal cell differentiation through a ΔNp63α axis, marks urothelial progenitor cells with self-renewal capacity, and interacts with translation initiation factor eIF4H via its N-terminal head domain to selectively promote ACOX2 mRNA translation, driving lipid metabolic reprogramming and chemoresistance in bladder cancer (PMID:36512409, PMID:27320313, PMID:41444318). KRT14 transcription is activated by EZH2-mediated H3K27me3 displacement of the SP1 repressor and post-transcriptionally regulated by lncRNA ABCE1-5-mediated mRNA destabilization, with KRT14 upregulation promoting invasion and metastasis in triple-negative breast cancer and pulmonary fibrosis through mTOR/AKT signaling (PMID:36446780, PMID:40111939).

1. 2006 High

   Establishing that different KRT14 domains cause distinct diseases resolved a long-standing question of how a single keratin gene could underlie both skin fragility and ectodermal dysplasia: N-terminal head domain truncations cause NFJS/DPR through increased basal cell apoptosis, distinct from rod domain mutations causing EBS.

   Evidence Genetic linkage and mutation analysis across 5 families with ultrastructural examination of patient skin

   PMID:16960809

   Open questions at the time

   • Mechanism by which head domain loss increases apoptosis was not defined at the molecular level
   • No rescue experiment to confirm causality
2. 2007 Medium

   Demonstrating that KRT14 knockdown sensitizes keratinocytes to TNF-α-induced apoptosis provided a mechanistic explanation for the NFJS/DPR phenotype, showing that KRT14 has a signaling-protective function beyond structural support.

   Evidence siRNA knockdown in HaCaT cells with TNF-α apoptosis assay and doxycycline rescue

   PMID:18049449

   Open questions at the time

   • Direct molecular target of KRT14 in anti-apoptotic signaling not identified
   • Only one cell line tested
3. 2008 Medium

   Complete KRT14 loss revealed the functional requirement for KRT14 in basal keratinocyte filament networks and the capacity for compensatory K6/K16 upregulation, establishing that K14 is not absolutely required for cell survival but is essential for normal filament architecture.

   Evidence Immunofluorescence and electron microscopy of homozygous KRT14-null patient skin biopsy

   PMID:18713255

   Open questions at the time

   • Single patient case
   • Functional consequences of K6/K16 compensation not tested
4. 2010 Medium

   Gene correction of dominant-negative KRT14 mutations restored normal skin graft histology, providing direct functional proof that mutant KRT14 protein actively disrupts filament polymerization rather than simply being non-functional.

   Evidence AAV-mediated gene targeting in human keratinocytes with transplantation to athymic mice

   PMID:20571545

   Open questions at the time

   • Long-term stability of correction in regenerating epidermis not assessed
5. 2011 High

   Systematic genotype-phenotype mapping across 76 EBS probands established that helix initiation motif mutations cause the most severe (Dowling-Meara) phenotype, while specific amino acid substitutions at the same position produce graded severity depending on structural distortion, defining the structure-function rules for KRT14 rod domain assembly.

   Evidence Large cohort KRT5/KRT14 sequencing with immunofluorescence; in silico modeling and in vitro transfection of Ala413 variants in HaCaT cells

   PMID:21375516 PMID:21593775

   Open questions at the time

   • No in vitro filament reconstitution to quantify assembly defects biochemically
   • Correlation between clumping severity and clinical severity not formally tested across large series
6. 2016 High

   KRT14 was established as a functional marker of self-renewing urothelial progenitors and cells of origin for urothelial carcinoma, revealing a role beyond structural support as a marker of stem-like basal cell identity.

   Evidence Krt14-Cre genetic lineage tracing in mouse urothelium with injury and tumor models

   PMID:27320313

   Open questions at the time

   • Whether KRT14 is functionally required for progenitor self-renewal or merely a marker was not distinguished
7. 2016 Medium

   Demonstrating that KRT14 promotes osteoblast mineralization upstream of mTOR signaling expanded KRT14's functional repertoire beyond epithelia, though the mechanism linking an intermediate filament to mTOR activation remained unclear.

   Evidence Krt14 siRNA knockdown in rat primary osteoblasts with mineralization assay and mTOR inhibitor treatment

   PMID:26956522

   Open questions at the time

   • Direct molecular link between KRT14 and mTOR activation not identified
   • Relevance to in vivo bone biology not tested
8. 2017 Medium

   Retinoic acid was identified as a direct upstream repressor of Krt14/Krt5 expression in developing salivary epithelium, establishing an extrinsic signaling input that controls basal keratin identity independently of stem cell programs.

   Evidence Isolated salivary gland epithelium explant cultures with RA signaling inhibition and qRT-PCR

   PMID:27884045

   Open questions at the time

   • Whether RA acts directly on KRT14 promoter or through intermediate transcription factors not resolved
   • Single tissue type tested
9. 2019 Medium

   Demonstrating that KRT14 loss abrogates ovarian cancer invasion without affecting proliferation established an invasion-specific, non-structural function for KRT14 in cancer, distinct from its mechanical role in normal epithelia.

   Evidence KRT14 knockdown in ovarian cancer spheroids with mesothelial clearance and invasion assays

   PMID:31443478

   Open questions at the time

   • Downstream effectors of KRT14-mediated invasion not identified
   • Single cancer type in vitro
10. 2022 High

    The discovery that EZH2 activates KRT14 transcription by depositing H3K27me3 to displace the repressor SP1 from the KRT14 promoter revealed an unexpected activating role for a canonically repressive histone mark and explained how KRT14 drives TNBC metastasis.

    Evidence ChIP-seq for H3K27me3 and SP1, KRT14 knockdown with in vitro migration/invasion and in vivo peritoneal metastasis models, EZH2 inhibitor treatment

    PMID:36446780

    Open questions at the time

    • Whether H3K27me3-mediated SP1 displacement is a general mechanism or specific to the KRT14 locus
    • Contribution of other transcription factors at the KRT14 promoter not assessed
11. 2023 High

    Identifying Krt14 as a direct binding partner of stratifin that controls ΔNp63α levels during airway basal cell differentiation provided the first mechanistic link between a keratin intermediate filament protein and a transcriptional differentiation program.

    Evidence CRISPR-KO in primary mouse airway basal cells, co-immunoprecipitation, differentiation assays, in vivo injury model

    PMID:36512409

    Open questions at the time

    • How Krt14-Sfn binding stabilizes Sfn protein not determined
    • Whether this axis operates in other KRT14-expressing epithelia unknown
12. 2025 High

    The discovery that KRT14 directly interacts with eIF4H through its N-terminal head domain to selectively promote ACOX2 translation revealed a previously unsuspected non-cytoskeletal function as a translational regulator, providing a mechanistic basis for KRT14-driven chemoresistance.

    Evidence Co-IP, GST pulldown, domain-mapping mutagenesis, polysome profiling, ACOX2 5'UTR reporter, xenograft models

    PMID:41444318

    Open questions at the time

    • Scope of KRT14-eIF4H translational targets beyond ACOX2 not defined
    • Whether this translational role is active in normal basal cells or only in cancer contexts
13. 2025 Medium

    Identification of lncRNA ABCE1-5 as a direct destabilizer of KRT14 mRNA added a post-transcriptional regulatory layer and linked KRT14 upregulation to mTOR/AKT-driven pulmonary fibrosis.

    Evidence RNA pulldown-mass spectrometry, RNA immunoprecipitation, KRT14 knockdown/overexpression in vitro and in vivo with bleomycin model

    PMID:40111939

    Open questions at the time

    • Mechanism of ABCE1-5-mediated mRNA destabilization (e.g., recruitment of decay machinery) not defined
    • Whether ABCE1-5 regulation of KRT14 operates in epithelial tissues beyond lung

• It remains unknown how KRT14's non-structural functions (translational regulation via eIF4H, differentiation control via Sfn, anti-apoptotic signaling) are coordinated and whether they depend on filament-incorporated versus soluble pools of KRT14 protein.
• No structural model of KRT14-eIF4H or KRT14-Sfn complexes exists
• Whether KRT14's signaling functions require filament assembly or act from the soluble pool is untested
• Genome-wide translational targets of the KRT14-eIF4H axis are undefined